EU Off-Patent Industry Sees ‘Limited Immediate Risk’ From COVID-19
But Coronavirus Could Have ‘Important Impact’ If Situation Continues
• By David Wallace
Medicines for Europe sees a limited immediate risk from the coronavirus outbreak, but the situation could worsen • Source: Shutterstock 
